SENS PubMed Publication Search
Association of Neurofibrillary Tangle Distribution With Age at Onset-Related Clinical Heterogeneity in Alzheimer Disease: An Autopsy Study
Neurology. 2021 Nov 22;10.1212/WNL.0000000000013107. doi: 10.1212/WNL.0000000000013107.
Denis S Smirnov 1, David P Salmon 1, Douglas Galasko 1 2, Vanessa S Goodwill 3, Lawrence A Hansen 3, Yu Zhao 4, Steven D Edland 4, Gabriel C Léger 1, Guerry M Peavy 1, Diane M Jacobs 1, Robert Rissman 1 2, Donald P Pizzo 3, Annie Hiniker 5 2 3
Abstract:
Background and objective: Patients with earlier age at onset of sporadic Alzheimer's Disease (AD) are more likely than those with later onset to present with atypical clinical and cognitive features. We sought to determine if this age-related clinical and cognitive heterogeneity is mediated by different topographical distributions of tau-aggregate neurofibrillary tangles (NFTs) or by variable amounts of concomitant non-AD neuropathology.
Methods: The relative distribution of NFT density in hippocampus and midfrontal neocortex was calculated, and α-synuclein, TDP-43, and microvascular co-pathologies were staged, in patients with severe AD and age at onset of 51-60 (n=40), 61-70 (n=41), and >70 (n=40) years. Regression, mediation, and mixed effects models examined relationships of pathological findings with clinical features and longitudinal cognitive decline.
Results: Patients with later age at onset of AD were less likely to present with non-memory complaints (OR=0.46 per decade, 95%CI: 0.22 - 0.88), psychiatric symptoms (β=-0.66, 95%CI: -1.15 - -0.17), and functional impairment (β=-1.25, 95%CI: -2.34 - -0.16). TDP-43 (OR = 2.00, 95%CI: 1.23 - 3.35) and microvascular co-pathology (OR = 2.02, 95%CI: 1.24 - 3.40) were more common in later onset AD, and α-synuclein co-pathology was not related to age at onset. NFT density in Midfrontal cortex (β = -0.51, 95% CI: -0.72 - -0.31) and Midfrontal/Hippocampal NFT ratio (β = -0.18, 95% CI: -0.26 - -0.10) were lower in those with later age at onset. Executive function (β = 0.48, 95% CI: 0.09 - 0.90) and visuospatial (β = 0.97, 95% CI: 0.46 - 1.46) cognitive deficits were less impaired in patients with later age at onset. Mediation analyses showed that the effect of age at onset on severity of executive function deficits was mediated by Midfrontal/Hippocampal NFT ratio (β = 0.21, 95% CI: 0.08 - 0.38) and not by concomitant non-AD pathologies. Midfrontal/Hippocampal NFT ratio also mediated an association between earlier age at onset and faster decline on tests of global cognition, executive function, and visuospatial abilities.
Discussion: Worse executive dysfunction and faster cognitive decline in people with sporadic AD with earlier rather than later age at onset is mediated by greater relative Midfrontal neocortical to hippocampal NFT burden and not by concomitant non-AD neuropathology.
Methods: The relative distribution of NFT density in hippocampus and midfrontal neocortex was calculated, and α-synuclein, TDP-43, and microvascular co-pathologies were staged, in patients with severe AD and age at onset of 51-60 (n=40), 61-70 (n=41), and >70 (n=40) years. Regression, mediation, and mixed effects models examined relationships of pathological findings with clinical features and longitudinal cognitive decline.
Results: Patients with later age at onset of AD were less likely to present with non-memory complaints (OR=0.46 per decade, 95%CI: 0.22 - 0.88), psychiatric symptoms (β=-0.66, 95%CI: -1.15 - -0.17), and functional impairment (β=-1.25, 95%CI: -2.34 - -0.16). TDP-43 (OR = 2.00, 95%CI: 1.23 - 3.35) and microvascular co-pathology (OR = 2.02, 95%CI: 1.24 - 3.40) were more common in later onset AD, and α-synuclein co-pathology was not related to age at onset. NFT density in Midfrontal cortex (β = -0.51, 95% CI: -0.72 - -0.31) and Midfrontal/Hippocampal NFT ratio (β = -0.18, 95% CI: -0.26 - -0.10) were lower in those with later age at onset. Executive function (β = 0.48, 95% CI: 0.09 - 0.90) and visuospatial (β = 0.97, 95% CI: 0.46 - 1.46) cognitive deficits were less impaired in patients with later age at onset. Mediation analyses showed that the effect of age at onset on severity of executive function deficits was mediated by Midfrontal/Hippocampal NFT ratio (β = 0.21, 95% CI: 0.08 - 0.38) and not by concomitant non-AD pathologies. Midfrontal/Hippocampal NFT ratio also mediated an association between earlier age at onset and faster decline on tests of global cognition, executive function, and visuospatial abilities.
Discussion: Worse executive dysfunction and faster cognitive decline in people with sporadic AD with earlier rather than later age at onset is mediated by greater relative Midfrontal neocortical to hippocampal NFT burden and not by concomitant non-AD neuropathology.
PMID: 34810247
Tags: Age at onset, Alzheimer’s, humans, neurofibrillary tangles, NFT